These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23676197)

  • 1. Quantitative damage-benefit evaluation of drug effects: major discrepancies between the general population, users and experts.
    Reynaud M; Luquiens A; Aubin HJ; Talon C; Bourgain C
    J Psychopharmacol; 2013 Jul; 27(7):590-9. PubMed ID: 23676197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A damage/benefit evaluation of addictive product use.
    Bourgain C; Falissard B; Blecha L; Benyamina A; Karila L; Reynaud M
    Addiction; 2012 Feb; 107(2):441-50. PubMed ID: 21954999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
    Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
    Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which substance is most dangerous? Perceived harm ratings among students in urban and rural Norway.
    Pedersen W; Von Soest T
    Scand J Public Health; 2015 Jun; 43(4):385-92. PubMed ID: 25816858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
    Bonnet U; Specka M; Kanti AK; Scherbaum N
    Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with psychoactive substance use among a sample of prison inmates in Ilesa, Nigeria.
    Amdzaranda PA; Fatoye FO; Oyebanji AO; Ogunro AS; Fatoye GK
    Niger Postgrad Med J; 2009 Jun; 16(2):109-14. PubMed ID: 19606190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social judgments of behavioral versus substance-related addictions: a population-based study.
    Konkolÿ Thege B; Colman I; el-Guebaly N; Hodgins DC; Patten SB; Schopflocher D; Wolfe J; Wild TC
    Addict Behav; 2015 Mar; 42():24-31. PubMed ID: 25462650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations?
    Robson P; Bruce M
    Addiction; 1997 Dec; 92(12):1729-36. PubMed ID: 9581005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.
    Moreno-López L; Stamatakis EA; Fernández-Serrano MJ; Gómez-Río M; Rodríguez-Fernández A; Pérez-García M; Verdejo-García A
    PLoS One; 2012; 7(6):e39830. PubMed ID: 22768136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying adolescent drug users: results of a national survey on adolescent health in Switzerland.
    Konings E; Dubois-Arber F; Narring F; Michaud PA
    J Adolesc Health; 1995 Mar; 16(3):240-7. PubMed ID: 7779836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-fatal injuries and the use of psychoactive drugs among young adults in Spain.
    Regidor E; Barrio G; de la Fuente L; Rodríguez C
    Drug Alcohol Depend; 1996 Mar; 40(3):249-59. PubMed ID: 8861404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increasing trends in screening for addictives behaviors among general practitioners in France].
    Beck F; Guignard R; Obradovic I; Gautier A; Karila L
    Rev Epidemiol Sante Publique; 2011 Oct; 59(5):285-94. PubMed ID: 21940125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of perceived parenting style on the propensity for illicit drug use: the importance of parental warmth and control.
    Montgomery C; Fisk JE; Craig L
    Drug Alcohol Rev; 2008 Nov; 27(6):640-9. PubMed ID: 18821098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychoactive substance use during pregnancy: a review].
    Lamy S; Thibaut F
    Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug consumption among the student population of Mexico City and its metropolitan area: subgroups affected and distribution of users.
    Castro ME; Valencia M
    Bull Narc; 1980; 32(4):29-37. PubMed ID: 6912078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use patterns and drug-related disorders of cocaine users in a sample of the general population in Germany.
    Kraus L; Augustin R; Kunz-Ebrecht S; Orth B
    Eur Addict Res; 2007; 13(2):116-25. PubMed ID: 17356284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.